当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析 - 现金流量表

瑞康医药

(002589)

  

流通市值:39.33亿  总市值:43.34亿
流通股本:13.66亿   总股本:15.05亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,050,813,443.423,928,977,071.761,858,405,712.598,610,726,176.2
  收到的税费返还18,391.22--384,878.51
  收到其他与经营活动有关的现金141,197,297.15126,836,780.0298,551,068.16983,787,571.15
  经营活动现金流入小计6,192,029,131.794,055,813,851.781,956,956,780.759,594,898,625.86
  购买商品、接受劳务支付的现金5,531,372,827.893,556,767,619.561,704,840,986.567,970,723,176.37
  支付给职工以及为职工支付的现金212,858,232.01142,824,353.8869,234,157.18310,500,127.75
  支付的各项税费96,633,053.0270,126,414.2537,036,383.99166,238,142.31
  支付其他与经营活动有关的现金310,588,836.18218,209,365.55102,819,104.26986,992,299.93
  经营活动现金流出小计6,151,452,949.13,987,927,753.241,913,930,631.999,434,453,746.36
  经营活动产生的现金流量净额40,576,182.6967,886,098.5443,026,148.76160,444,879.5
二、投资活动产生的现金流量:
  收回投资收到的现金0--174,394,283.83
  取得投资收益收到的现金20,513,453.578,806,344.084,310,762.6196,321.46
  处置固定资产、无形资产和其他长期资产收回的现金净额17,109,490.4615,310,562.866,985,050.33750,306.98
  处置子公司及其他营业单位收到的现金净额54,751,353.3537,377,573.4813,743,747.3226,272,268.5
  收到的其他与投资活动有关的现金280,000,000170,000,000-659,935,021.64
  投资活动现金流入小计372,374,297.38231,494,480.4225,039,560.231,061,548,202.41
  购建固定资产、无形资产和其他长期资产支付的现金99,479,265.7377,126,743.9624,396,079.85111,528,429.13
  投资支付的现金---83,950,600
  支付其他与投资活动有关的现金400,000,000290,000,000-662,091,793.04
  投资活动现金流出小计499,479,265.73367,126,743.9624,396,079.85857,570,822.17
  投资活动产生的现金流量净额-127,104,968.35-135,632,263.54643,480.38203,977,380.24
三、筹资活动产生的现金流量:
  吸收投资收到的现金20,000,00020,000,000-0
  其中:子公司吸收少数股东投资收到的现金20,000,00020,000,000--
  取得借款收到的现金2,185,382,046.771,788,053,603.211,371,148,453.622,712,537,743.5
  收到其他与筹资活动有关的现金11,131,983,290.377,320,684,452.834,065,429,137.2118,646,150,525.47
  筹资活动现金流入小计13,337,365,337.149,128,738,056.045,436,577,590.8321,358,688,268.97
  偿还债务支付的现金3,250,924,326.482,289,329,415.891,793,511,022.522,961,022,602.21
  分配股利、利润或偿付利息支付的现金181,126,511.31119,097,382.5173,506,658.48198,706,434.71
  其中:子公司支付给少数股东的股利、利润21,000,000--0
  支付其他与筹资活动有关的现金10,018,814,417.636,574,377,996.813,329,910,526.0418,345,434,035.99
  筹资活动现金流出小计13,450,865,255.428,982,804,795.215,196,928,207.0421,505,163,072.91
  筹资活动产生的现金流量净额-113,499,918.28145,933,260.83239,649,383.79-146,474,803.94
五、现金及现金等价物净增加额-200,028,703.9478,187,095.83283,319,012.93217,947,455.8
  加:期初现金及现金等价物余额690,322,926.07690,322,926.07689,889,358.53471,941,902.73
  期末现金及现金等价物余额490,294,222.13768,510,021.9973,208,371.46689,889,358.53
补充资料:
  净利润-30,605,041.88-41,017,810.26
  资产减值准备--53,240,838.15-69,614,649.77
  固定资产和投资性房地产折旧-58,460,173.46-123,253,688.89
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-58,460,173.46-123,253,688.89
  无形资产摊销-28,045,236.08-72,707,914.38
  长期待摊费用摊销-9,269,254.63-16,908,760.95
  处置固定资产、无形资产和其他长期资产的损失--173,176.52--18,938,795.04
  固定资产报废损失--1,486,722.43-613,628.5
  公允价值变动损失-890,896.12--30,647,078.86
  财务费用-117,884,999.14-193,866,434.08
  投资损失--12,404,896.21--96,213,121.33
  递延所得税--45,300,699.75--684,134.14
  其中:递延所得税资产减少--42,678,969.24--1,705,017.97
    递延所得税负债增加--2,621,730.51-1,020,883.83
  存货的减少--77,583,304.12-385,037,580.88
  经营性应收项目的减少--98,682,537.85-61,010,422.2
  经营性应付项目的增加-110,657,557.8--660,284,218.26
  现金的期末余额-768,510,021.9-689,889,358.53
  减:现金的期初余额-690,322,926.07-471,941,902.73
  现金及现金等价物的净增加额-78,187,095.83-217,947,455.8
公告日期2025-10-302025-08-262025-04-302025-04-24
审计意见(境内)标准无保留意见
TOP↑